Home » Topics » Regulatory

Regulatory
RSS

Roberts seeks to broaden market for Agrylin

Jan. 13, 1998

Ares-Serono's recombinant IFN-beta1a recommended for approval by CPMP for MS

Jan. 9, 1998

FDA clears Optison

Jan. 8, 1998

NDA filed for betamethasone mousse

Jan. 7, 1998

Astra to launch new tablet formulation of Losec in Sweden

Jan. 7, 1998

FDA clears new Allegra product; Seldane to be withdrawn

Jan. 7, 1998

Faulding establishes new U.S. division, regains rights to Kadian

Jan. 7, 1998

NDA filed for extended-release Ditropan formulation

Dec. 29, 1997

Alferon evaluated in patients coinfected with HIV and HCV

Dec. 29, 1997

FDA approval obtained for Prandin

Dec. 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Pharma industry faces long haul to get return on investment from AI
BioWorld Science
Artificial intelligence tools are springing up at multiple points along drug discovery and development, but despite the hype, as yet there is minimal return on...